自拟益气消痰祛瘀固肾汤治疗中风病恢复期的临床研究

The Clinical Research on Yiqi Phlegm Quyu Gushen Decoction in the Recovery of Stroke Patients

目的观察分析自拟益气消痰祛瘀固肾汤治疗中风病恢复期的临床疗效。方法 160例患者按随机数字表法随机分为观察组和对照组。两组均采用西医常规治疗。对照组给予常规脑复康静脉滴注合并长春西汀静滴。观察组在西医常规治疗基础上联合自拟益气消痰祛瘀固肾汤治疗。观察两组临床疗效、美国国立卫生研究院卒中量表（NIHSS）评分、巴塞尔指数（Barthel）评分以及生活能力评价的变化。结果观察组总有效率为95.00%,明显高于对照组的80.00%（P〈0.05）。两组治疗前NIHSS评分及Barthel评分均差别不大（均P〉0.05）。两组治疗后两项评分均较治疗前改善,NIHSS评分下降,而Barthel指数升高（均P〈0.05）,且观察组改善优于对照组（均P〈0.05）。观察组治疗后生活能力评价在1级~0级者占37.50%,高于对照组的21.25%（P〈0.05）;而观察组生活能力评价在4级或以下者占27.50%,低于对照组的46.25%（P〈0.05）。结论自拟益气消痰祛瘀固肾汤治疗中风病恢复期具有较好疗效,可以促进患者神经功能恢复,提高其生活能力。

Objective： To observe and analyze the clinical efficacy of yiqi phlegm quyu gushen decoction on stroke recovery. Methods： 160 cases were randomly divided into the observation group and the control group. The control group were treated with conventional Western medicine treatment. Patients in the observation group, on the basis of western medicine,were treated with yiqi phlegm quyu gushen decoction. Results： The effective rate of the observation group was 95.0%, significantly higher than that of the control group 80.00% （P 〈 0.05 ）. Be- fore treatment,NIHSS score and Barthel score were not statistically significant between the two groups （P〉 0.05）. After treatment,there were significant improvements in scores- NIHSS scores declined significantly,while the Barthel index improved （P〈 0.05）,and the observation group was better than the control group. After treatment, living capacity assessment in 1 to 0 level of the observation group reached 37.5%,higher than that of the control group 21.25% （P〈 0.05）. Living capacity assessment below level 4 of the observation group reached 27.5%,lower than that of the control group 46.25% （P〈 0.05）. Conclusion： Yiqi phlegm quyu gushen decoction can achieve satisfactory therapeutic effect on Stroke recovery, nerve function and the patient＇s ability to live better.